Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
|Videos|January 11, 2015
Advantages of Having Pharmacists on the Antimicrobial Stewardship Team
J. Russell May, PharmD, FASHP, clinical professor at Georgia Regents University College of Pharmacy, discusses the advantages of having pharmacists on the antimicrobial stewardship team.
Advertisement
J. Russell May, PharmD, FASHP, clinical professor at Georgia Regents University College of Pharmacy, discusses the advantages of having pharmacists on the antimicrobial stewardship team.
This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.
Advertisement
Related to this article
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
New European Respiratory Society (ERS) update makes sotatercept a strong add-on recommendation, opening a fourth pathway for pharmacists to manage.
At the 2026 New England Institute of Ambulatory Care Pharmacists (NEIAP) Annual Forum, Jennifer Goldman detailed how monitoring data drive engagement—and how a new dual sensor readies pharmacists for ketone alerts.
With nearly 8 in 10 older adults misusing at least 1 OTC product, clearer counseling and labels could close the gap.
Contraceptive access gaps driven by federal rollbacks, provider shortages, and stalled state legislation could be narrowed by letting trained pharmacists prescribe birth control independently.
Cancer diagnoses among civilians exposed to 9/11 dust keep rising, with strained health programs struggling to meet growing needs.
With childhood immunization rates sliding and outbreaks accelerating, pharmacist-led counseling and vaccine administration can boost vaccination rates.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Adult Pneumococcal Immunizations: A Practical Guide for Pharmacists
2
How Pharmacists Overcome PCSK9 Inhibitor Access Barriers
3
FDA Approves Rebisufligene Etisparvovec as First Gene Therapy for Children With Sanfilippo Syndrome Type A
4
Beyond Cost Avoidance: Advancing Unit-Level Pharmaceutical Economics in Health Systems
5